pharmaceuticals
pharmaceuticals Articles
Arrowhead Pharmaceuticals shares made a considerable gain early on Thursday after the firm announced data from its hepatitis B clinical trial with ARO-HBV.
Published:
Last Updated:
Clinical-stage biopharmaceutical company Principia Biopharma has amended its filing with the SEC for its initial public offering.
Published:
Last Updated:
BioCryst Pharmaceuticals shares fell on Tuesday after the company announced initial results from its hereditary angioedema trial.
Published:
Last Updated:
Clinical-stage drug maker Sutro Biopharma has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
InsysTherapeutics shares made a handy gain early on Thursday after the company announced an update from the FDA.
Published:
Last Updated:
Akcea and Ionis were each crushed on Tuesday after the firms announced that they received a Complete Response Letter from the FDA.
Published:
Last Updated:
Pfizer shares slipped on Monday despite the company posting positive results from a late-stage tafamidis trial.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
Kala Pharmaceuticals shares dipped on Thursday after the U.S. Food and Drug Administration (FDA) announced that it had approved INVELTYS (loteprednol etabonate ophthalmic suspension) 1% for the...
Published:
Last Updated:
Big Pharma is looking good for investors in the second half of 2018. That's the message from the research team at Bank of America Merrill Lynch.
Published:
Last Updated:
Amneal Pharma shares hit a post-IPO high in Monday’s session after the company announced a new licensing and supply agreement.
Published:
Last Updated:
24/7 Wall St. has identified several biotech analyst calls from Wall Street wherein the analysts are projecting upside of 100% to about 400%.
Published:
Last Updated:
Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it.
Published:
Last Updated:
Teva and Regeneron both saw handy gains on Thursday after the companies posted positive topline results from their late-stage trial of fasinumab in patients with chronic pain from osteoarthritis...
Published:
Last Updated:
Vertex Pharmaceuticals shares saw a handy gain on Thursday after the FDA gave a nod to Vertex’s cystic fibrosis treatment.
Published:
Last Updated: